\relax 
\providecommand\hyper@newdestlabel[2]{}
\@writefile{toc}{\contentsline {section}{Supplementary materials of chapter 2}{160}{section*.124}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{Waveform and Action Potential properties manifold \\ comparison }{160}{section*.125}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {6.1}{\ignorespaces (\textbf  {a}) Overlaid UMAP representation FN and SH waveforms from 186 neuron used in classification. The waveform shapes are different between SH and FN protocols.(\textbf  {b}) FN and SH Action potential parameters used for classification projected together on the same space. The Action potential properties are different between FN and SH protocols. The SH Action potential properties show a bigger spread than FN properties. (\textbf  {c}) UMAP projection of averaged Waveform comparison between the first half and the entire trial. The average waveform shape doesn't change as a result of trial length. }}{160}{figure.caption.126}\protected@file@percent }
\newlabel{first:app1}{{6.1}{160}{(\textbf {a}) Overlaid UMAP representation FN and SH waveforms from 186 neuron used in classification. The waveform shapes are different between SH and FN protocols.(\textbf {b}) FN and SH Action potential parameters used for classification projected together on the same space. The Action potential properties are different between FN and SH protocols. The SH Action potential properties show a bigger spread than FN properties. (\textbf {c}) UMAP projection of averaged Waveform comparison between the first half and the entire trial. The average waveform shape doesn't change as a result of trial length}{figure.caption.126}{}}
\@writefile{toc}{\contentsline {section}{Louvain vs Ensemble Clustering for Graphs (ECG) algorithm comparison }{161}{section*.127}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {6.2}{\ignorespaces (\textbf  {a}) UMAP embedding of FN waveforms colored with cluster labels found using Ensemble clustering, with original waveforms in the same color as the respective color. 7 clusters were observed, the same number as in the case of the Louvain community method. (\textbf  {b}) UMAP embedding of SH waveforms colored with cluster labels found using Ensemble clustering, with original waveforms in the same color as the respective color. 7 clusters were observed, the same number as in the case of the Louvain community method. }}{161}{figure.caption.128}\protected@file@percent }
\newlabel{first:app2}{{6.2}{161}{(\textbf {a}) UMAP embedding of FN waveforms colored with cluster labels found using Ensemble clustering, with original waveforms in the same color as the respective color. 7 clusters were observed, the same number as in the case of the Louvain community method. (\textbf {b}) UMAP embedding of SH waveforms colored with cluster labels found using Ensemble clustering, with original waveforms in the same color as the respective color. 7 clusters were observed, the same number as in the case of the Louvain community method}{figure.caption.128}{}}
\@writefile{toc}{\contentsline {section}{Cluster stability after leaving one attribute out at a time}{163}{section*.130}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {6.3}{\ignorespaces (\textbf  {a-b}) Stability of clusters for action potential attributes leaving one attribute out for excitatory and Inhibitory sets. The clustering was performed 25 times with random 80\% samples for resolution attributes ranging from 0.0 to 1, the mean and standard deviation of the resulting number of clusters and modularity score are plotted. For the chosen resolution parameter (1.0), the cluster numbers fluctuate between 5-7. The cluster number fluctuates more for the excitatory set (left) than the Inhibitory set (right) (\textbf  {c-d}) Stability of clusters for biophysical attributes leaving one attribute out for excitatory and Inhibitory sets. The clustering was performed 25 times with random 90\% samples for resolution parameters ranging from 0.0 to 1, the mean and standard deviation of the resulting number of clusters and modularity score are plotted. For the chosen resolution parameter (1.0), the excitatory population fluctuates between 6-8. On the contrary, the Inhibitory population doesn't show any fluctuation.}}{163}{figure.caption.131}\protected@file@percent }
\newlabel{first:app3}{{6.3}{163}{(\textbf {a-b}) Stability of clusters for action potential attributes leaving one attribute out for excitatory and Inhibitory sets. The clustering was performed 25 times with random 80\% samples for resolution attributes ranging from 0.0 to 1, the mean and standard deviation of the resulting number of clusters and modularity score are plotted. For the chosen resolution parameter (1.0), the cluster numbers fluctuate between 5-7. The cluster number fluctuates more for the excitatory set (left) than the Inhibitory set (right) (\textbf {c-d}) Stability of clusters for biophysical attributes leaving one attribute out for excitatory and Inhibitory sets. The clustering was performed 25 times with random 90\% samples for resolution parameters ranging from 0.0 to 1, the mean and standard deviation of the resulting number of clusters and modularity score are plotted. For the chosen resolution parameter (1.0), the excitatory population fluctuates between 6-8. On the contrary, the Inhibitory population doesn't show any fluctuation}{figure.caption.131}{}}
\@writefile{toc}{\contentsline {section}{Diversity of firing rate and AP half-width}{164}{section*.132}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {6.4}{\ignorespaces Firing rate vs AP half-width between excitatory (red) and inhibitory (blue) populations. The excitatory population has a lower firing rate and higher AP width. The Inhibitory population has a lower AP width and higher firing rate.}}{164}{figure.caption.133}\protected@file@percent }
\newlabel{first:app4}{{6.4}{164}{Firing rate vs AP half-width between excitatory (red) and inhibitory (blue) populations. The excitatory population has a lower firing rate and higher AP width. The Inhibitory population has a lower AP width and higher firing rate}{figure.caption.133}{}}
\@writefile{toc}{\contentsline {section}{STA Heterogeneity}{165}{section*.134}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {6.5}{\ignorespaces {(\textbf  {a}) The scatter plot shows the baseline added to the theoretical input vs the Peak distance of the STA. The excitatory population has a higher baseline and higher peak distance. The variance for both baseline and peak distance seems higher for the excitatory population than inhibitory population. (\textbf  {b}) The STA cosine similarity is for the excitatory population (top left), the STA cosine similarity is for the inhibitory population (top right), and the STA cosine similarity is between the excitatory and inhibitory populations. The excitatory population has higher similarity than the inhibitory population.}}}{165}{figure.caption.135}\protected@file@percent }
\newlabel{first:app5}{{6.5}{165}{(\textbf {a}) The scatter plot shows the baseline added to the theoretical input vs the Peak distance of the STA. The excitatory population has a higher baseline and higher peak distance. The variance for both baseline and peak distance seems higher for the excitatory population than inhibitory population. (\textbf {b}) The STA cosine similarity is for the excitatory population (top left), the STA cosine similarity is for the inhibitory population (top right), and the STA cosine similarity is between the excitatory and inhibitory populations. The excitatory population has higher similarity than the inhibitory population}{figure.caption.135}{}}
\@writefile{toc}{\contentsline {section}{Cluster assignment likelihood across attributes}{166}{section*.136}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {6.6}{\ignorespaces (\textbf  {a-e}) Heatmap showing the likelihood for neuron clustering in attribute 1 clustering }}{166}{figure.caption.137}\protected@file@percent }
\newlabel{first:app6}{{6.6}{166}{(\textbf {a-e}) Heatmap showing the likelihood for neuron clustering in attribute 1 clustering}{figure.caption.137}{}}
\@writefile{toc}{\contentsline {section}{Supplementary materials of chapter 3}{168}{section*.139}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {6.7}{\ignorespaces \textbf  {Clustering likelihood matrix and cosine similarity across labels shifts for all four properties as a result of neuromodulation for D1-R, D2-R and M1-R}}}{169}{figure.caption.140}\protected@file@percent }
\newlabel{fig:S1_ref}{{6.7}{169}{\textbf {Clustering likelihood matrix and cosine similarity across labels shifts for all four properties as a result of neuromodulation for D1-R, D2-R and M1-R}}{figure.caption.140}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {6.8}{\ignorespaces \textbf  {Comparison of aCSF trial 1 vs trial 2 clustering and manifold}}}{170}{figure.caption.142}\protected@file@percent }
\newlabel{fig:S2}{{6.8}{170}{\textbf {Comparison of aCSF trial 1 vs trial 2 clustering and manifold}}{figure.caption.142}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {6.9}{\ignorespaces \textbf  {D2 receptor activation changes functional clustering and attributes for both excitatory and inhibitory neurons.} }}{171}{figure.caption.144}\protected@file@percent }
\newlabel{fig:S3_ref}{{6.9}{171}{\textbf {D2 receptor activation changes functional clustering and attributes for both excitatory and inhibitory neurons.}}{figure.caption.144}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {6.10}{\ignorespaces \textbf  {M1 receptor activation changes functional clustering and attributes for both excitatory and inhibitory neurons.}}}{173}{figure.caption.146}\protected@file@percent }
\newlabel{fig:S4_ref}{{6.10}{173}{\textbf {M1 receptor activation changes functional clustering and attributes for both excitatory and inhibitory neurons.}}{figure.caption.146}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {6.11}{\ignorespaces \textbf  {Adaptation current peaks and decay times are not strongly altered by D1, D2 and M1 modulation} The scatter plots show the normalized peaks of the AC curve on the x-axis and the decay time for D1, D2 and M1 vs aCSF trials. The red panel represents excitatory and blue panel represents inhibitory. * $p<0.05$, ** $p<0.001$, *** $p<0.0001$.}}{175}{figure.caption.148}\protected@file@percent }
\newlabel{fig:S5}{{6.11}{175}{\textbf {Adaptation current peaks and decay times are not strongly altered by D1, D2 and M1 modulation} The scatter plots show the normalized peaks of the AC curve on the x-axis and the decay time for D1, D2 and M1 vs aCSF trials. The red panel represents excitatory and blue panel represents inhibitory. * $p<0.05$, ** $p<0.001$, *** $p<0.0001$}{figure.caption.148}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {6.12}{\ignorespaces \textbf  {Spike triggered average peaks and decay times are modestly altered by D1, D2 and M1 modulation} The scatter plots show the normalized peaks of the STA curve on the x-axis and the decay time for D1, D2 and M1 vs aCSF trials. The red panel represents excitatory and blue panel represents inhibitory population. * $p<0.05$, ** $p<0.001$, *** $p<0.0001$}}{176}{figure.caption.149}\protected@file@percent }
\newlabel{fig:S6}{{6.12}{176}{\textbf {Spike triggered average peaks and decay times are modestly altered by D1, D2 and M1 modulation} The scatter plots show the normalized peaks of the STA curve on the x-axis and the decay time for D1, D2 and M1 vs aCSF trials. The red panel represents excitatory and blue panel represents inhibitory population. * $p<0.05$, ** $p<0.001$, *** $p<0.0001$}{figure.caption.149}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {6.13}{\ignorespaces \textbf  {Average cosine similarity across and within aCSF-Agonist trials vary in a cell-type specific manner.} (\textbf  {A}) Heatmaps show the average AC similarity for excitatory (red background) and inhibitory (blue background) for D1, D2 and M1 vs aCSF trials. (\textbf  {B}) Heatmaps show the average STA similarities for excitatory (red background) and inhibitory (blue background) for D1, D2 and M1 vs aCSF trials.}}{177}{figure.caption.150}\protected@file@percent }
\newlabel{fig:S7}{{6.13}{177}{\textbf {Average cosine similarity across and within aCSF-Agonist trials vary in a cell-type specific manner.} (\textbf {A}) Heatmaps show the average AC similarity for excitatory (red background) and inhibitory (blue background) for D1, D2 and M1 vs aCSF trials. (\textbf {B}) Heatmaps show the average STA similarities for excitatory (red background) and inhibitory (blue background) for D1, D2 and M1 vs aCSF trials}{figure.caption.150}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {6.14}{\ignorespaces \textbf  {Clustering based on differences between control and D2 for action potential and passive biophysical attributes reveals subgroups of neurons getting modulated differently as a result of D2-R activation.}}}{178}{figure.caption.151}\protected@file@percent }
\newlabel{fig:S8}{{6.14}{178}{\textbf {Clustering based on differences between control and D2 for action potential and passive biophysical attributes reveals subgroups of neurons getting modulated differently as a result of D2-R activation.}}{figure.caption.151}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {6.15}{\ignorespaces \textbf  {Clustering based on differences between control and M1 for action potential and passive biophysical attributes reveals subgroups of neurons getting modulated differently as a result of M1-R activation.}}}{180}{figure.caption.153}\protected@file@percent }
\newlabel{fig:S9}{{6.15}{180}{\textbf {Clustering based on differences between control and M1 for action potential and passive biophysical attributes reveals subgroups of neurons getting modulated differently as a result of M1-R activation.}}{figure.caption.153}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {6.16}{\ignorespaces \textbf  {MCFA for 1st and 2nd aCSF trials.}}}{182}{figure.caption.155}\protected@file@percent }
\newlabel{fig:S10}{{6.16}{182}{\textbf {MCFA for 1st and 2nd aCSF trials.}}{figure.caption.155}{}}
\@writefile{lot}{\contentsline {table}{\numberline {6.1}{\ignorespaces Statistical comparison of fractional information (FI) changes under receptor activation.}}{183}{table.caption.156}\protected@file@percent }
\newlabel{tab:table1}{{6.1}{183}{Statistical comparison of fractional information (FI) changes under receptor activation}{table.caption.156}{}}
\@writefile{lot}{\contentsline {table}{\numberline {6.2}{\ignorespaces \textbf  {Excitatory MCFA results}. Values that are reduced compared to bootstrapped aCSF are colored in red and values that are increased compared to aCSF are colored in blue. }}{184}{table.caption.157}\protected@file@percent }
\newlabel{tab:specific_values_exc}{{6.2}{184}{\textbf {Excitatory MCFA results}. Values that are reduced compared to bootstrapped aCSF are colored in red and values that are increased compared to aCSF are colored in blue}{table.caption.157}{}}
\@writefile{lot}{\contentsline {table}{\numberline {6.3}{\ignorespaces \textbf  {Inhibitory MCFA results}. Values that are reduced compared to bootstrapped aCSF are colored in red and values that are increased compared to aCSF are colored in blue. }}{185}{table.caption.158}\protected@file@percent }
\newlabel{tab:specific_values_inh}{{6.3}{185}{\textbf {Inhibitory MCFA results}. Values that are reduced compared to bootstrapped aCSF are colored in red and values that are increased compared to aCSF are colored in blue}{table.caption.158}{}}
\@writefile{lot}{\contentsline {table}{\numberline {6.4}{\ignorespaces \textbf  {Excitatory MCFA results for second aCSF trial}. Values that are reduced compared to bootstrapped aCSF trial 1 are colored in red and values that are increased compared to aCSF trial 1 are colored in blue.}}{186}{table.caption.159}\protected@file@percent }
\newlabel{tab:specific_values_exc_acsf}{{6.4}{186}{\textbf {Excitatory MCFA results for second aCSF trial}. Values that are reduced compared to bootstrapped aCSF trial 1 are colored in red and values that are increased compared to aCSF trial 1 are colored in blue}{table.caption.159}{}}
\@writefile{lot}{\contentsline {table}{\numberline {6.5}{\ignorespaces \textbf  {Inhibitory MCFA results for second aCSF trial}. Values that are reduced compared to bootstrapped aCSF trial 1 are colored in red and values that are increased compared to aCSF trial 1 are colored in blue. }}{187}{table.caption.160}\protected@file@percent }
\newlabel{tab:specific_values_inh_acsf}{{6.5}{187}{\textbf {Inhibitory MCFA results for second aCSF trial}. Values that are reduced compared to bootstrapped aCSF trial 1 are colored in red and values that are increased compared to aCSF trial 1 are colored in blue}{table.caption.160}{}}
\bibstyle{apalike}
\bibdata{All_bibtex}
\@setckpt{Chapters/Supplementary_Materials}{
\setcounter{page}{188}
\setcounter{equation}{0}
\setcounter{enumi}{4}
\setcounter{enumii}{0}
\setcounter{enumiii}{0}
\setcounter{enumiv}{0}
\setcounter{footnote}{0}
\setcounter{mpfootnote}{0}
\setcounter{part}{0}
\setcounter{chapter}{6}
\setcounter{section}{0}
\setcounter{subsection}{0}
\setcounter{subsubsection}{0}
\setcounter{paragraph}{0}
\setcounter{subparagraph}{0}
\setcounter{figure}{16}
\setcounter{table}{5}
\setcounter{caption@flags}{2}
\setcounter{continuedfloat}{0}
\setcounter{subfigure}{0}
\setcounter{subtable}{0}
\setcounter{NAT@ctr}{25}
\setcounter{KVtest}{0}
\setcounter{parentequation}{0}
\setcounter{nlinenum}{0}
\setcounter{float@type}{4}
\setcounter{LT@tables}{0}
\setcounter{LT@chunks}{0}
\setcounter{tblrcount}{0}
\setcounter{r@tfl@t}{0}
\setcounter{lofdepth}{1}
\setcounter{lotdepth}{1}
\setcounter{section@level}{0}
\setcounter{Item}{13}
\setcounter{Hfootnote}{0}
\setcounter{Hy@AnnotLevel}{0}
\setcounter{bookmark@seq@number}{6}
}
